Bladder Cancer

Real-world outcomes of definitive chemoradiotherapy for bladder cancer: a multi-institutional retrospective study in Japan. June 11, 2026

Mixture cure model analysis of event-free survival in the NIAGARA Trial: Quantifying the cure fraction benefit of perioperative durvalumab in muscle-invasive bladder cancer. June 10, 2026

Photocure and Artera to Partner on Digital Pathology AI Test Evaluation for Bladder Cancer June 8, 2026

Impact of CKD on perioperative outcomes following TURBT: a national NSQIP analysis. June 8, 2026

Photocure ASA to Acquire Vesica Health Inc., Strengthening Leadership in Bladder Cancer Diagnostics June 5, 2026

Epidemiological Trends and Germline Variant Analysis of Young-Onset Bladder Cancer. June 5, 2026

Sarcopenia Weakens the Benefit of Bacillus Calmette-Guérin in Non-Muscle-Invasive Bladder Cancer: A Computed Tomography-Based Cohort Study. June 5, 2026

An advanced in vitro bladder cancer model integrating bladder cancer spheroids into a healthy human urothelium for preclinical therapeutic testing. June 4, 2026

Radiogenomic analysis of muscle-invasive bladder cancer using CT-based texture analysis. June 3, 2026

Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment in Metastatic Urothelial Cancer: A Randomized Phase II Study of Two Alternative Dosing Schedules. June 2, 2026

External Validation of A Decision Tree Model for Predicting Cancer-Specific Mortality After Radical Cystectomy: A Multi-Center Study in South-East Spain. June 11, 2026

Targeting HER2 in Urothelial Carcinoma: Why Histologic Subtypes and Divergent Histologies Matter. June 10, 2026

Survival Outcomes of a Smoking Cessation Treatment Program After Diagnosis of Bladder Cancer. June 8, 2026

Effect of marital status on years of life lost from metastatic bladder cancer according to sex and race/ethnicity. June 8, 2026

Collecting electronic patient-reported outcomes via smartphone text messages in a bladder cancer RCT: A feasibility study. June 5, 2026

Genomic analysis of BCG unresponsive non-muscle-invasive bladder cancer identifies drivers of sensitivity to intravesical Gemcitabine/Docetaxel. June 5, 2026

A machine-learning approach to predict additional treatment after Bacillus Calmette-Guérin induction in non-muscle-invasive bladder cancer. June 4, 2026

10-yr Outcomes of Senior Clinical Fellowship in Robot-assisted Radical Cystectomy (RARC) with focus on Intracorporeal Ileal Conduit Urinary Diversion: Aggregated Learning Curve Assessment and Achievement of the EAU-Robotic Urology Section (ERUS) RARC Curr June 4, 2026

Evolution of treatment and oncological outcomes in patients undergoing radical cystectomy: a comparative analysis across two decades at a tertiary center. June 3, 2026

What's next for VI-RADS? Updates and future perspectives from the ACR VI-RADS steering committee. June 2, 2026

Page 1 of 602